ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
15.94
+0.26 (1.66%)
Aug 23, 2024, 4:00 PM EDT - Market closed
ACADIA Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
Net Income | 30.57 | -61.29 | -215.98 | -167.87 | -281.58 | -235.26 | |
Depreciation & Amortization | 11.46 | 5.55 | 2.03 | 3.34 | 2.93 | 2.77 | |
Loss (Gain) From Sale of Assets | - | - | - | - | 0.28 | 0 | |
Asset Writedown & Restructuring Costs | - | - | - | - | 44.28 | - | |
Loss (Gain) From Sale of Investments | -9 | -12.12 | -6.28 | 0.08 | 2.47 | -4.61 | |
Stock-Based Compensation | 67 | 66.42 | 68.2 | 63.62 | 84.42 | 82.27 | |
Change in Accounts Receivable | -21.85 | -36.07 | 2.17 | -16.12 | -12.47 | -9.69 | |
Change in Inventory | -70.08 | -28.81 | 2.42 | -4.21 | -3.32 | -1.74 | |
Change in Accounts Payable | 1.07 | 4.8 | 5.87 | -1.62 | 1.27 | 4.06 | |
Change in Other Net Operating Assets | 71.37 | 78.22 | 27.54 | -2.88 | 25.55 | 11.08 | |
Operating Cash Flow | 80.53 | 16.7 | -114.04 | -125.66 | -136.17 | -151.13 | |
Capital Expenditures | -0.05 | -0.05 | - | -1.12 | -7.59 | -1.13 | |
Sale (Purchase) of Intangibles | - | -40 | - | - | - | - | |
Investment in Securities | -36.42 | 72.05 | 73.24 | -69.98 | 200.1 | -164.71 | |
Investing Cash Flow | -36.47 | 32 | 73.24 | -71.1 | 192.51 | -165.84 | |
Issuance of Common Stock | 22.79 | 25.13 | 8.2 | 18.16 | 81 | 371.85 | |
Financing Cash Flow | 22.79 | 25.13 | 8.2 | 18.16 | 81 | 371.85 | |
Foreign Exchange Rate Adjustments | -0.01 | -0.02 | 0.01 | 0.01 | -0.01 | 0 | |
Net Cash Flow | 66.84 | 73.81 | -32.59 | -178.59 | 137.33 | 54.88 | |
Free Cash Flow | 80.48 | 16.65 | -114.04 | -126.78 | -143.75 | -152.26 | |
Free Cash Flow Margin | 9.04% | 2.29% | -22.05% | -26.19% | -32.54% | -44.90% | |
Free Cash Flow Per Share | 0.49 | 0.10 | -0.71 | -0.79 | -0.91 | -1.03 | |
Cash Income Tax Paid | 5.85 | 5.85 | 2.19 | 1.04 | 1.11 | 1.6 | |
Levered Free Cash Flow | 130.44 | 28.44 | -34.96 | -65.26 | -59.7 | -68.6 | |
Unlevered Free Cash Flow | 130.44 | 28.44 | -34.96 | -65.26 | -59.7 | -68.6 | |
Change in Net Working Capital | -37.77 | -42.38 | -34.56 | 24.58 | -6.65 | -1.59 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.